Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies - PubMed (original) (raw)

Synthetic peptides from four separate regions of the poliovirus type 1 capsid protein VP1 induce neutralizing antibodies

M Chow et al. Proc Natl Acad Sci U S A. 1985 Feb.

Abstract

Peptides from different regions of the poliovirus type 1 capsid protein VP1 were synthesized. Antibodies raised against these peptides in rabbits and rats recognized the cognate peptides and denatured VP1. Peptides from four regions of VP1 generated antisera with neutralizing titers specifically against poliovirus type 1. Antisera against all other regions of VP1 failed to neutralize virus infectivity, although some of the antisera clearly bound to native virions. Thus, the neutralizing determinants on VP1 reside in specific noncontiguous regions of the protein and can be defined by specific peptides from these regions.

PubMed Disclaimer

Similar articles

• Isolated poliovirus capsid protein VP1 induces a neutralizing response in rats.
  Chow M, Baltimore D. Chow M, et al. Proc Natl Acad Sci U S A. 1982 Dec;79(23):7518-21. doi: 10.1073/pnas.79.23.7518. Proc Natl Acad Sci U S A. 1982. PMID: 6296837 Free PMC article.
• A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
  Wychowski C, van der Werf S, Siffert O, Crainic R, Bruneau P, Girard M. Wychowski C, et al. EMBO J. 1983;2(11):2019-24. doi: 10.1002/j.1460-2075.1983.tb01694.x. EMBO J. 1983. PMID: 6196195 Free PMC article.
• Induction of neutralizing antibodies by type 1 poliovirus VP1 capsid polypeptide.
  Crainic R, Blondel B, Horaud F. Crainic R, et al. Dev Biol Stand. 1983;55:185-9. Dev Biol Stand. 1983. PMID: 6329856
• Immunochemical studies of polioviruses: identification of immunoreactive virus capsid polypeptides.
  Thorpe R, Minor PD, Mackay A, Schild GC, Spitz M. Thorpe R, et al. J Gen Virol. 1982 Dec;63(2):487-92. doi: 10.1099/0022-1317-63-2-487. J Gen Virol. 1982. PMID: 6185628
• Ability of linear and cyclic peptides of neutralization antigenic site 1 of poliovirus type 1 to induce virus cross-reactive and neutralizing antibodies.
  van der Werf S, Briand JP, Plaué S, Burckard J, Girard M, Van Regenmortel MH. van der Werf S, et al. Res Virol. 1994 Nov-Dec;145(6):349-59. doi: 10.1016/s0923-2516(07)80040-9. Res Virol. 1994. PMID: 7535942

Cited by

• Identification of T-helper epitopes in the VP1 capsid protein of poliovirus.
  Kutubuddin M, Simons J, Chow M. Kutubuddin M, et al. J Virol. 1992 May;66(5):3042-7. doi: 10.1128/JVI.66.5.3042-3047.1992. J Virol. 1992. PMID: 1373200 Free PMC article.
• Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin.
  Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cunningham MW, et al. Proc Natl Acad Sci U S A. 1992 Feb 15;89(4):1320-4. doi: 10.1073/pnas.89.4.1320. Proc Natl Acad Sci U S A. 1992. PMID: 1311095 Free PMC article.
• The N-terminal region of the VP1 protein of swine vesicular disease virus contains a neutralization site that arises upon cell attachment and is involved in viral entry.
  Jiménez-Clavero MA, Escribano-Romero E, Douglas AJ, Ley V. Jiménez-Clavero MA, et al. J Virol. 2001 Jan;75(2):1044-7. doi: 10.1128/JVI.75.2.1044-1047.2001. J Virol. 2001. PMID: 11134318 Free PMC article.
• Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
  Li Q, Yafal AG, Lee YM, Hogle J, Chow M. Li Q, et al. J Virol. 1994 Jun;68(6):3965-70. doi: 10.1128/JVI.68.6.3965-3970.1994. J Virol. 1994. PMID: 7514682 Free PMC article.
• B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface.
  Langeveld JP, Casal JI, Vela C, Dalsgaard K, Smale SH, Puijk WC, Meloen RH. Langeveld JP, et al. J Virol. 1993 Feb;67(2):765-72. doi: 10.1128/JVI.67.2.765-772.1993. J Virol. 1993. PMID: 7678305 Free PMC article.

References

1. 1. J Virol. 1970 Jun;5(6):677-81 - PubMed
2. 1. J Exp Med. 1959 Jul 1;110(1):65-80 - PubMed
3. 1. Virology. 1976 May;71(1):207-16 - PubMed
4. 1. Biochemistry. 1979 Feb 20;18(4):690-3 - PubMed
5. 1. Clin Chem. 1979 Sep;25(9):1572-80 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Europe PubMed Central
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Molecular Biology Databases

  • Immune Epitope Database and Analysis Resource